Skip to main content
All lobbying filings

Splitoak Strategies LLC

Splitoak Strategies LLC filed a Q1 report for Caris Science Inc. on May 4, 2026, reporting $40,000 in lobbying income.

Lobbying for Caris Science Inc. · Providing precision medicine services to patients battling aggressive cancers.

As filed: SPLITOAK STRATEGIES LLC for CARIS SCIENCE INC.

All filings by Splitoak Strategies LLC · Everything Caris Science Inc. has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted May 4, 2026
Income
$40,000
What the client paid this registrant for the period.
Client based in
Texas

Official filing document

 Lobbyists on this filing 1
  • AMY JENSEN
    Previously held: Special Assistant to the President for Legislative Affairs; Assistant to the Speaker for Policy; Legislative Assistant; Policy Analyst

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Medicare/Medicaid

Role of molecular profiling in cancer care; access to molecular profiling technologies and multi-cancer testing in Medicare; prior authorization reform in Medicare and appropriate reimbursement for cutting edge cancer diagnostic testing; HR 5269 RESULTS Act; HR 7148 the Consolidated Appropriations Act of 2026; updated timing of reporting under PAMA

Health Issues

Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem